Biomarkers in Prediction of AMI
ConditionAcute Mesenteric Ischemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Tartu
About this trial
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
Eligibility criteria
Qualifiers
Age 18 years or older
Initial decision in favour of further diagnostics of mesenteric ischaemia
Disqualifiers
Age <18 years
Consent declined by patient or next of kin (delayed consent)
Chronic mesenteric ischaemia without an acute event
Immediate decision for withdrawal of further diagnostics and active treatment
Trial design
Treatments tested in this trial
- Sequential blood samples
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov